publicaciones seleccionadas artículo académico Design and functional characterization of Salmo salar TLR5 agonist peptides derived from high mobility group B1 acidic tail. FISH & SHELLFISH IMMUNOLOGY. 146. 2024 Identification of Cryptosporidium parvum and Blastocystis hominis subtype ST3 in Cholga mussel and treated sewage: Preliminary evidence of fecal contamination in harvesting area. FOOD AND WATERBORNE PARASITOLOGY . 34. 2024 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(6). 2023 FISH & SHELLFISH IMMUNOLOGY. FISH & SHELLFISH IMMUNOLOGY. 125:120-127. 2022 VITAMIN C DEFICIENCY REDUCES NEUROGENESIS AND PROLIFERATION IN THE SVZ AND LATERAL VENTRICLE EXTENSIONS OF THE YOUNG GUINEA PIG BRAIN. ANTIOXIDANTS. 11(10). 2022 CURCUMA AS AN ADJUVANT IN COLORECTAL CANCER TREATMENT. LIFE SCIENCES. 286. 2021 VITAMIN C DEFICIENT REDUCES PROLIFERATION IN A HUMAN PERIVENTRICULAR TUMOR STEM CELL-DERIVED GLIOBLASTOMA MODEL. JOURNAL OF CELLULAR PHYSIOLOGY. 2021 BIOMOLECULES. BIOMOLECULES. 10(3). 2020 DRIMYS WINTERI AND ISODRIMENINOL DECREASED FOAM CELL FORMATION IN THP-1 DERIVED MACROPHAGES. FOOD AND CHEMICAL TOXICOLOGY. 146. 2020 PHYTOCHEMICAL AND CRYSTALLOGRAPHIC STUDIES OF AZARA DENTATA EXTRACTS AND ITS CYTOTOXIC EFFECTS ON HUMAN BREAST CANCER CELL, MCF-7. JOURNAL OF THE CHILEAN CHEMICAL SOCIETY. 65(3):4891-4894. 2020 EXPRESSION AND CHARACTERIZATION OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCED IN SIHA CELLS TRANSDUCED WITH ADENOVIRAL VECTOR. PROTEIN JOURNAL. 38(6):693-703. 2019 FISH & SHELLFISH IMMUNOLOGY. FISH & SHELLFISH IMMUNOLOGY. 88:587-594. 2019 LOX-1 ACTIVATION BY OXLDL TRIGGERS AN EPITHELIAL MESENCHYMAL TRANSITION AND PROMOTES TUMORIGENIC POTENTIAL IN PROSTATE CANCER CELLS. CANCER LETTERS. 414:34-43. 2018 NEUROPROTECTIVE EFFECT OF A NEW VARIANT OF EPO NONHEMATOPOIETIC AGAINST OXIDATIVE STRESS. REDOX BIOLOGY. 14:285-294. 2018 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 467(4):1039-1045. 2015 LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 IS AN ENHANCER OF TUMOR ANGIOGENESIS IN HUMAN PROSTATE CANCER CELLS. PLOS ONE. 9(8):1-11. 2014